Literature DB >> 33203547

Galectins in allergic inflammatory diseases.

Lei Wan1, Yu-An Hsu2, Chang-Ching Wei3, Fu-Tong Liu4.   

Abstract

Allergic inflammatory diseases are a global public health concern affecting millions of people. Although there are several potential hypotheses, details regarding their molecular mechanisms are still ambiguous. Recently, a group of β-galactoside-binding proteins, galectins, have been revealed as important factors in altering allergic chronic inflammatory diseases. In this review, we describe the molecular and cellular basis of how galectins modulate inflammatory reactions. We also provide an overview of clinical features related to galectins. Finally, we discuss the potential issues that might lead to misrepresentation of the exact biological functions of galectins.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Allergic diseases; Allergic inflammation; Allergy; Galectin

Year:  2020        PMID: 33203547     DOI: 10.1016/j.mam.2020.100925

Source DB:  PubMed          Journal:  Mol Aspects Med        ISSN: 0098-2997


  3 in total

Review 1.  Unraveling How Tumor-Derived Galectins Contribute to Anti-Cancer Immunity Failure.

Authors:  Diego José Laderach; Daniel Compagno
Journal:  Cancers (Basel)       Date:  2021-09-09       Impact factor: 6.575

Review 2.  Functions and Inhibition of Galectin-7, an Emerging Target in Cellular Pathophysiology.

Authors:  Nishant V Sewgobind; Sanne Albers; Roland J Pieters
Journal:  Biomolecules       Date:  2021-11-18

3.  LGALS2 suppresses the progression of papillary thyroid carcinoma by regulating the PI3K/AKT pathway.

Authors:  Debin Xu; Liangyun Guo; Shuyong Zhang; Qian Hou
Journal:  Gland Surg       Date:  2022-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.